A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Conditions: Advanced Solid Tumor; Melanoma; Head and Neck Cancer; Gastric Cancer Interventions: Drug: HER3-DXd Sponsors: Daiichi Sankyo, Inc.; Merck Sharp& Dohme LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials